Literature DB >> 29364738

Mutation Analysis of Families with Autosomal Dominant Congenital Cataract: A Recurrent Mutation in the CRYBA1/A3 Gene Causing Congenital Nuclear Cataract.

Kai Jie Wang1, Xu Zha2, Dou Dou Chen1, Si Quan Zhu1.   

Abstract

PURPOSE: To identify the CRYBA1/A3 mutation spectrum and analyze the genotype-phenotype correlations in Chinese families with congenital cataract.
METHODS: Family history and clinical data of 47 unrelated families with autosomal dominant congenital cataract (ADCC) were recorded. CRYBA1/A3 gene sequencing was applied to identify the causative mutation. Haplotypes were constructed using closely linked microsatellite markers and intragenic single-nucleotide polymorphisms (SNPs) to compare the affected haplotype in three families.
RESULTS: Nuclear cataract was the most common type of ADCC in Chinese families, accounting for 42.6% (20/47). A recurrent CRYBA1/A3 deletion mutation (ΔG91) was identified in three families (6.4%) with nonprogressive nuclear congenital cataract. Different haplotypes segregated with the mutation in each family.
CONCLUSIONS: A recurrent ΔG91CRYBA1/A3 mutation occurs independently in 6.4% of the Chinese families with autosomal dominant nuclear cataracts and most likely represents a mutational hot spot, which underscores the relations between nonprogressive nuclear cataract and CRYBA1/A3.

Entities:  

Keywords:  CRYBA1/A3; Congenital cataract; haplotype; hot spot; mutation

Mesh:

Substances:

Year:  2018        PMID: 29364738     DOI: 10.1080/02713683.2017.1406527

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  Congenital Cataract and Its Genetics: The Era of Next-Generation Sequencing

Authors:  Hande Taylan Şekeroğlu; Gülen Eda Utine
Journal:  Turk J Ophthalmol       Date:  2021-04-29

2.  The identification and characterization of the p.G91 deletion in CRYBA1 in a Chinese family with congenital cataracts.

Authors:  Dan Li; Qinghe Jing; Yongxiang Jiang
Journal:  BMC Med Genet       Date:  2019-09-05       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.